4 stories about Gastro
default image

Gastro Treatment Company RedHill Announces Successful Clinical Trial in Treatment of H. Pylori Infection

RedHill’s new pill managed to eradicate 84% of H. pylori bacteria, as opposed to 58% in patients receiving the standard of care
נאסד"ק וול סטריט

RedHill’s Clinical Trial Results Undermine Its Underwritten Offering

12.08.18|Dror Reich
The gastro treatment company announced a successful Crohn's disease treatment trial two weeks ago. While investors initially seemed hyped, successful trials from competitors brought RedHill’s stock down since
נאסד"ק וול סטריט

Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq

24.07.18|Lilach Baumer
The Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market
colospan device

Gastro Medical Device Startup Raises $8 Million

01.10.17|Lilach Baumer
Israel-based Colospan develops a device that prevents inner-body leaks after intestinal surgery